{"count": 78, "results": [{"_id": "35302255", "pmid": 35302255, "pmcid": "PMC9151475", "title": "Effect of preoperative administration of atenolol to dogs with pulmonic stenosis undergoing interventional procedures", "journal": "J Vet Intern Med", "authors": ["Gomart S", "MacFarlane P", "Payne JR", "Hezzell MJ", "Borgeat K"], "date": "2022-05-01T00:00:00Z", "doi": "10.1111/jvim.16403", "meta_date_publication": "2022 May", "meta_volume": "36", "meta_issue": "3", "meta_pages": "877-885", "score": 50260.13, "text_hl": "To evaluate if pretreatment with @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ reduces frequency of @<m>DISEASE_Arrhythmias_Cardiac</m> @DISEASE_MESH:D001145 @@@ventricular arrhythmias@@@, anesthetist interventions, or shortens procedure time.", "citations": {"NLM": "Gomart S, MacFarlane P, Payne JR, Hezzell MJ, Borgeat K. Effect of preoperative administration of atenolol to dogs with pulmonic stenosis undergoing interventional procedures J Vet Intern Med. 2022 May;36(3):877-885. PMID: 35302255", "BibTeX": "@article{35302255, title={Effect of preoperative administration of atenolol to dogs with pulmonic stenosis undergoing interventional procedures}, author={Gomart S and MacFarlane P and Payne JR and Hezzell MJ and Borgeat K}, journal={J Vet Intern Med}, volume={36}, number={3}, pages={877-885}}"}}, {"_id": "40384969", "pmid": 40384969, "title": "Case Report: High efficacy of low-dose flecainide as an add-on therapy to a beta-blocker for treating a high burden of idiopathic ventricular arrhythmias in a juvenile athlete.", "journal": "Front Cardiovasc Med", "authors": ["Christou GA", "Letsas KP", "Konstandi M", "Christou MA", "Christou KA", "Kyriakopoulos C", "Vidalakis E", "Tigas S", "Christodoulou DK", "Kiortsis DN"], "date": "2025-05-02T00:00:00Z", "doi": "10.3389/fcvm.2025.1537078", "meta_date_publication": "2025", "meta_volume": "12", "meta_issue": "", "meta_pages": "1537078", "score": 50253.33, "text_hl": "After adding @CHEMICAL_Flecainide @CHEMICAL_MESH:D005424 @@@flecainide@@@ 25 mg twice daily to @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ treatment, 24-h ambulatory electrocardiographic monitoring revealed complete resolution of @<m>DISEASE_Arrhythmias_Cardiac</m> @DISEASE_MESH:D001145 @@@ventricular arrhythmias@@@, with no @DISEASE_Ventricular_Premature_Complexes @DISEASE_MESH:D018879 @@@PVCs@@@ detected. ", "citations": {"NLM": "Christou GA, Letsas KP, Konstandi M, Christou MA, Christou KA, Kyriakopoulos C, Vidalakis E, Tigas S, Christodoulou DK, Kiortsis DN. Case Report: High efficacy of low-dose flecainide as an add-on therapy to a beta-blocker for treating a high burden of idiopathic ventricular arrhythmias in a juvenile athlete. Front Cardiovasc Med. 2025;12():1537078. PMID: 40384969", "BibTeX": "@article{40384969, title={Case Report: High efficacy of low-dose flecainide as an add-on therapy to a beta-blocker for treating a high burden of idiopathic ventricular arrhythmias in a juvenile athlete.}, author={Christou GA and Letsas KP and Konstandi M and Christou MA and Christou KA and Kyriakopoulos C and Vidalakis E and Tigas S and Christodoulou DK and Kiortsis DN}, journal={Front Cardiovasc Med}, volume={12}, pages={1537078}}"}}, {"_id": "37438479", "pmid": 37438479, "title": "Cytoskeletal disarray increases arrhythmogenic vulnerability during sympathetic stimulation in a model of hypertrophic cardiomyopathy.", "journal": "Sci Rep", "authors": ["Cserne Szappanos H", "Viola HM", "Ito DW", "Lim S", "Mangala M", "Holliday M", "Barratt Ross S", "Semsarian C", "Hill A", "Dixon RE", "Hool LC"], "date": "2023-07-12T00:00:00Z", "doi": "10.1038/s41598-023-38296-2", "meta_date_publication": "2023 Jul 12", "meta_volume": "13", "meta_issue": "1", "meta_pages": "11296", "score": 50240.58, "text_hl": "Following in vivo administration of @CHEMICAL_Isoproterenol @CHEMICAL_MESH:D007545 @@@isoproterenol@@@, mutant mice exhibited @DISEASE_Tachycardia @DISEASE_MESH:D013610 @@@tachyarrhythmias@@@, poor recovery and @DISEASE_Fatigue @DISEASE_MESH:D005221 @@@fatigue@@@. @<m>DISEASE_Arrhythmias_Cardiac</m> @DISEASE_MESH:D001145 @@@Arrhythmias@@@ were attenuated with the beta-blocker @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ and protein kinase A inhibitor PKI. ", "citations": {"NLM": "Cserne Szappanos H, Viola HM, Ito DW, Lim S, Mangala M, Holliday M, Barratt Ross S, Semsarian C, Hill A, Dixon RE, Hool LC. Cytoskeletal disarray increases arrhythmogenic vulnerability during sympathetic stimulation in a model of hypertrophic cardiomyopathy. Sci Rep. 2023 Jul 12;13(1):11296. PMID: 37438479", "BibTeX": "@article{37438479, title={Cytoskeletal disarray increases arrhythmogenic vulnerability during sympathetic stimulation in a model of hypertrophic cardiomyopathy.}, author={Cserne Szappanos H and Viola HM and Ito DW and Lim S and Mangala M and Holliday M and Barratt Ross S and Semsarian C and Hill A and Dixon RE and Hool LC}, journal={Sci Rep}, volume={13}, number={1}, pages={11296}}"}}, {"_id": "32124390", "pmid": 32124390, "title": "Adverse effects of interactions between antipsychotics and medications used in the treatment of cardiovascular disorders.", "journal": "Pharmacol Rep", "authors": ["Siwek M", "Woroń J", "Gorostowicz A", "Wordliczek J"], "date": "2020-04-01T00:00:00Z", "doi": "10.1007/s43440-020-00058-6", "meta_date_publication": "2020 Apr", "meta_volume": "72", "meta_issue": "2", "meta_pages": "350-359", "score": 50233.99, "text_hl": "RESULTS: The highest number of interactions with antipsychotics was recorded among beta-blockers (n = 13, 25% of all cases), including @<m>DISEASE_Arrhythmias_Cardiac</m> @DISEASE_MESH:D001145 @@@cardiac arrhythmias@@@ [@DISEASE_Atrial_Fibrillation @DISEASE_MESH:D001281 @@@atrial fibrillation@@@ (n = 1): @CHEMICAL_Risperidone @CHEMICAL_MESH:D018967 @@@risperidone@@@ plus @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@; @DISEASE_Bradycardia @DISEASE_MESH:D001919 @@@bradycardia@@@ (n = 1): @CHEMICAL_Perphenazine @CHEMICAL_MESH:D010546 @@@perphenazine@@@ with @CHEMICAL_Metoprolol @CHEMICAL_MESH:D008790 @@@metoprolol@@@; @<m>DISEASE_Arrhythmias_Cardiac</m> @DISEASE_MESH:D001145 @@@ventricular arrhythmias@@@: @CHEMICAL_sertindole @CHEMICAL_MESH:C066304 @@@sertindole@@@ with @CHEMICAL_Metoprolol @CHEMICAL_MESH:D008790 @@@metoprolol@@@ (n = 1) and @CHEMICAL_ziprasidone @CHEMICAL_MESH:C092292 @@@ziprasidone@@@ with @CHEMICAL_Sotalol @CHEMICAL_MESH:D013015 @@@sotalol@@@ (n = 3)] and @DISEASE_Hypotension @DISEASE_MESH:D007022 @@@hypotension@@@ [@CHEMICAL_Chlorprothixene @CHEMICAL_MESH:D002749 @@@chlorprotixene@@@ with @CHEMICAL_Nebivolol @CHEMICAL_MESH:D000068577 @@@nebivolol@@@ or @CHEMICAL_Metoprolol @CHEMICAL_MESH:D008790 @@@metoprolol@@@ (n = 2)]. 12 cases concerned statins-@DISEASE_Myalgia @DISEASE_MESH:D063806 @@@myalgia@@@, @DISEASE_Muscular_Diseases @DISEASE_MESH:D009135 @@@myopathy@@@, or creatine kinase elevation appeared after combination of @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ with @CHEMICAL_Haloperidol @CHEMICAL_MESH:D006220 @@@haloperidol@@@ (n = 1), @CHEMICAL_Quetiapine_Fumarate @CHEMICAL_MESH:D000069348 @@@quetiapine@@@ (n = 3) or @CHEMICAL_Risperidone @CHEMICAL_MESH:D018967 @@@risperidone@@@ (n = 1), and @CHEMICAL_Simvastatin @CHEMICAL_MESH:D019821 @@@simvastatin@@@ with @CHEMICAL_Quetiapine_Fumarate @CHEMICAL_MESH:D000069348 @@@quetiapine@@@ (n = 5) or @CHEMICAL_Risperidone @CHEMICAL_MESH:D018967 @@@risperidone@@@ (n = 2). ", "citations": {"NLM": "Siwek M, Woroń J, Gorostowicz A, Wordliczek J. Adverse effects of interactions between antipsychotics and medications used in the treatment of cardiovascular disorders. Pharmacol Rep. 2020 Apr;72(2):350-359. PMID: 32124390", "BibTeX": "@article{32124390, title={Adverse effects of interactions between antipsychotics and medications used in the treatment of cardiovascular disorders.}, author={Siwek M and Woroń J and Gorostowicz A and Wordliczek J}, journal={Pharmacol Rep}, volume={72}, number={2}, pages={350-359}}"}}, {"_id": "32310006", "pmid": 32310006, "title": "Treatment for beta-blocker poisoning: a systematic review.", "journal": "Clin Toxicol (Phila)", "authors": ["Rotella JA", "Greene SL", "Koutsogiannis Z", "Graudins A", "Hung Leang Y", "Kuan K", "Baxter H", "Bourke E", "Wong A"], "date": "2020-10-01T00:00:00Z", "doi": "10.1080/15563650.2020.1752918", "meta_date_publication": "2020 Oct", "meta_volume": "58", "meta_issue": "10", "meta_pages": "943-983", "score": 50222.516, "text_hl": "@CHEMICAL_Lidocaine @CHEMICAL_MESH:D008012 @@@Lignocaine@@@: There were four case reports showing variable response to @CHEMICAL_Lidocaine @CHEMICAL_MESH:D008012 @@@lignocaine@@@ in @<m>DISEASE_Arrhythmias_Cardiac</m> @DISEASE_MESH:D001145 @@@arrhythmias@@@ secondary to beta-blocker @DISEASE_Drug_Related_Side_Effects_and_Adverse_Reactions @DISEASE_MESH:D064420 @@@toxicity@@@.Other treatments: @CHEMICAL_Fructosediphosphates @CHEMICAL_MESH:D005635 @@@Fructose diphosphate@@@, @CHEMICAL_Simendan @CHEMICAL_MESH:D000077464 @@@levosimendan@@@ and @CHEMICAL_Amrinone @CHEMICAL_MESH:D000676 @@@amrinone@@@ did not provide a mortality or significant haemodynamic benefit in three animal studies and nine case reports. .Veno-arterial extracorporeal membrane oxygenation: Veno-arterial extracorporeal membrane oxygenation was associated with improved survival in @SPECIES_9606 @@@patients@@@ with severe @DISEASE_Shock_Cardiogenic @DISEASE_MESH:D012770 @@@cardiogenic shock@@@ or @DISEASE_Heart_Arrest @DISEASE_MESH:D006323 @@@cardiac arrest@@@ in an observational study and four cases series.Dialysis: The evidence of four case reports suggest haemodialysis may assist in the management of massive @DISEASE_Drug_Overdose @DISEASE_MESH:D062787 @@@overdose@@@ of specific water-soluble beta-blockers (e.g., @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@) by improving elimination; however, a survival or haemodynamic benefit was not established.Pacing: One case series and a single case report showed the utility of temporary overdrive cardiac pacing to prevent @<m>DISEASE_Arrhythmias_Cardiac</m> @DISEASE_MESH:D001145 @@@arrhythmias@@@ in @CHEMICAL_Sotalol @CHEMICAL_MESH:D013015 @@@sotalol@@@ @DISEASE_Drug_Related_Side_Effects_and_Adverse_Reactions @DISEASE_MESH:D064420 @@@toxicity@@@.Conclusions: @CHEMICAL_Catecholamines @CHEMICAL_MESH:D002395 @@@Catecholamines@@@, vasopressors, high-dose @GENE_INS @GENE_3630 @@@insulin@@@ euglycaemic therapy and veno-arterial extracorporeal membrane oxygenation were associated with reduced mortality. ", "citations": {"NLM": "Rotella JA, Greene SL, Koutsogiannis Z, Graudins A, Hung Leang Y, Kuan K, Baxter H, Bourke E, Wong A. Treatment for beta-blocker poisoning: a systematic review. Clin Toxicol (Phila). 2020 Oct;58(10):943-983. PMID: 32310006", "BibTeX": "@article{32310006, title={Treatment for beta-blocker poisoning: a systematic review.}, author={Rotella JA and Greene SL and Koutsogiannis Z and Graudins A and Hung Leang Y and Kuan K and Baxter H and Bourke E and Wong A}, journal={Clin Toxicol (Phila)}, volume={58}, number={10}, pages={943-983}}"}}, {"_id": "4003239", "pmid": 4003239, "title": "Reduction of ventricular arrhythmias by atenolol.", "journal": "Am Heart J", "authors": ["Heng MK", "Zimmer I"], "date": "1985-06-01T00:00:00Z", "doi": "10.1016/0002-8703(85)90351-5", "meta_date_publication": "1985 Jun", "meta_volume": "109", "meta_issue": "6", "meta_pages": "1273-80", "score": 50091.28, "text_hl": "Reduction of @<m>DISEASE_Arrhythmias_Cardiac</m> @DISEASE_MESH:D001145 @@@ventricular arrhythmias@@@ by @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@.", "citations": {"NLM": "Heng MK, Zimmer I. Reduction of ventricular arrhythmias by atenolol. Am Heart J. 1985 Jun;109(6):1273-80. PMID: 4003239", "BibTeX": "@article{4003239, title={Reduction of ventricular arrhythmias by atenolol.}, author={Heng MK and Zimmer I}, journal={Am Heart J}, volume={109}, number={6}, pages={1273-80}}"}}, {"_id": "3529912", "pmid": 3529912, "title": "Intravenous atenolol for ventricular arrhythmias.", "journal": "Am J Cardiol", "authors": ["Morganroth J"], "date": "1986-09-01T00:00:00Z", "doi": "10.1016/0002-9149(86)90023-8", "meta_date_publication": "1986 Sep 1", "meta_volume": "58", "meta_issue": "6", "meta_pages": "499-502", "score": 50090.96, "text_hl": "Intravenous @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ for @<m>DISEASE_Arrhythmias_Cardiac</m> @DISEASE_MESH:D001145 @@@ventricular arrhythmias@@@.", "citations": {"NLM": "Morganroth J. Intravenous atenolol for ventricular arrhythmias. Am J Cardiol. 1986 Sep 1;58(6):499-502. PMID: 3529912", "BibTeX": "@article{3529912, title={Intravenous atenolol for ventricular arrhythmias.}, author={Morganroth J}, journal={Am J Cardiol}, volume={58}, number={6}, pages={499-502}}"}}, {"_id": "2353617", "pmid": 2353617, "title": "Atenolol in children with ventricular arrhythmias.", "journal": "Am Heart J", "authors": ["Trippel DL", "Gillette PC"], "date": "1990-06-01T00:00:00Z", "doi": "10.1016/s0002-8703(05)80180-2", "meta_date_publication": "1990 Jun", "meta_volume": "119", "meta_issue": "6", "meta_pages": "1312-6", "score": 50090.78, "text_hl": "@<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@Atenolol@@@ in children with @<m>DISEASE_Arrhythmias_Cardiac</m> @DISEASE_MESH:D001145 @@@ventricular arrhythmias@@@.", "citations": {"NLM": "Trippel DL, Gillette PC. Atenolol in children with ventricular arrhythmias. Am Heart J. 1990 Jun;119(6):1312-6. PMID: 2353617", "BibTeX": "@article{2353617, title={Atenolol in children with ventricular arrhythmias.}, author={Trippel DL and Gillette PC}, journal={Am Heart J}, volume={119}, number={6}, pages={1312-6}}"}}, {"_id": "6517730", "pmid": 6517730, "title": "[Electrophysiological and anti-arrhythmia effects of atenolol].", "journal": "Arq Bras Cardiol", "authors": ["Pimenta J", "Pereira CB"], "date": "1984-06-01T00:00:00Z", "meta_date_publication": "1984 Jun", "meta_volume": "42", "meta_issue": "6", "meta_pages": "407-10", "score": 50088.066, "text_hl": "[Electrophysiological and anti-@<m>DISEASE_Arrhythmias_Cardiac</m> @DISEASE_MESH:D001145 @@@arrhythmia@@@ effects of @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@].", "citations": {"NLM": "Pimenta J, Pereira CB. [Electrophysiological and anti-arrhythmia effects of atenolol]. Arq Bras Cardiol. 1984 Jun;42(6):407-10. PMID: 6517730", "BibTeX": "@article{6517730, title={[Electrophysiological and anti-arrhythmia effects of atenolol].}, author={Pimenta J and Pereira CB}, journal={Arq Bras Cardiol}, volume={42}, number={6}, pages={407-10}}"}}, {"_id": "28982831", "pmid": 28982831, "pmcid": "PMC5640024", "title": "Association of asthma-chronic obstructive pulmonary disease overlap syndrome with coronary artery disease, cardiac dysrhythmia and heart failure: a population-based retrospective cohort study", "journal": "BMJ Open", "authors": ["Yeh JJ", "Wei YF", "Lin CL", "Hsu WH"], "date": "2017-10-05T00:00:00Z", "doi": "10.1136/bmjopen-2017-017657", "meta_date_publication": "2017 Oct 5", "meta_volume": "7", "meta_issue": "10", "meta_pages": "e017657", "score": 50083.316, "text_hl": "The aHR of @<m>CHEMICAL_Atenolol</m> @CHEMICAL_MESH:D001262 @@@atenolol@@@ treatment for @<m>DISEASE_Arrhythmias_Cardiac</m> @DISEASE_MESH:D001145 @@@CD@@@ was 1.72 (1.01 to 2.93). ", "citations": {"NLM": "Yeh JJ, Wei YF, Lin CL, Hsu WH. Association of asthma-chronic obstructive pulmonary disease overlap syndrome with coronary artery disease, cardiac dysrhythmia and heart failure: a population-based retrospective cohort study BMJ Open. 2017 Oct 5;7(10):e017657. PMID: 28982831", "BibTeX": "@article{28982831, title={Association of asthma-chronic obstructive pulmonary disease overlap syndrome with coronary artery disease, cardiac dysrhythmia and heart failure: a population-based retrospective cohort study}, author={Yeh JJ and Wei YF and Lin CL and Hsu WH}, journal={BMJ Open}, volume={7}, number={10}, pages={e017657}}"}}]}